Yisong Wang

3.3k citations
52 papers · 2.1k indexed · h-index 26
Topics
Lung Cancer Treatments and Mutations (9 papers)Cancer-related Molecular Pathways (7 papers)Myasthenia Gravis and Thymoma (6 papers)
Partner nations
United StatesChinaSweden

In The Last Decade

Yisong Wang

49 papers receiving 2.0k citations

Peers

Yisong Wang
Comparison fields: 5 of 103
  • Molecular Biology 1.1k
  • Oncology 793
  • Neurology 483
  • Pulmonary and Respiratory Medicine 304
  • Cancer Research 241
Replace Alexander Valent with:
Alexander Valent France
Agnès Ribeiro France
Laura Harrington United Kingdom
Raymond R. Mattingly United States
Lin Pei United States
Elmar Kirches Germany
Ulf Dahl Sweden
Kazunori Hamamura Japan
Zhifeng Dong China
Gabriella De Vita Italy
Yisong Wang relative to Alexander Valent France Alexander Valent's profile →
Citations per field
00.5×3.1×
Alexander Valent · 1×
Citations per year

Countries citing papers authored by Yisong Wang

Since Specialization
Citations

This map shows the geographic impact of Yisong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yisong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yisong Wang more than expected).

Fields of papers citing papers by Yisong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yisong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yisong Wang. The network helps show where Yisong Wang may publish in the future.

Co-authorship network of co-authors of Yisong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yisong Wang. A scholar is included among the top collaborators of Yisong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yisong Wang. Yisong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 16
2 0
3 6
4 31
5 3
6 10
7 33
8 197
9 26
10 98
11 22
12 25
13 47
14 23
15 55
16 24
17 12
18 8
19 42
20 0

About Yisong Wang

Yisong Wang is a scholar working on Oncology, Aging and Pulmonary and Respiratory Medicine, having authored 52 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Cancer-related Molecular Pathways (7 papers) and Myasthenia Gravis and Thymoma (6 papers). The work is most often cited by research in Neurology (483 citations), Oncology (793 citations) and Aging (32 citations). Yisong Wang has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Giuseppe Giaccone, Yie Liu, Klas G. Wiman, László Székely, Arun Rajan, George Klein, Iacopo Petrini, İsmail Okan, Paul S. Meltzer and John R. Dunlap. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026